Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackson T Wright

Showing results (111-120 of 189) with videos related to

Pageof 19
Sort By:
Archives of Internal Medicine|April 27, 2005
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Sara Pressel, Barry R Davis, et al.
JAMA Cardiology|March 23, 2017
Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney DiseaseJing Chen, Matthew J Budoff, Muredach P Reilly, et al.
Kidney International|July 17, 2014
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention TrialCarl D Langefeld, Jasmin Divers, Nicholas M Pajewski, et al.
Global Heart|February 19, 2024
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of HypertensionAnthony Rodgers, Abdul Salam, William Cushman, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
The rationale and design of the AASK cohort studyLawrence J Appel, John Middleton, Edgar R Miller, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Genetic African Ancestry and Markers of Mineral Metabolism in CKDOrlando M Gutiérrez, Afshin Parsa, Tamara Isakova, et al.
JAMA|November 21, 2002
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJackson T Wright, George Bakris, Tom Greene, et al.
Hypertension (Dallas, Tex. : 1979)|July 28, 2010
Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary studyRaymond R Townsend, Julio A Chirinos, Afshin Parsa, et al.
Archives of Internal Medicine|May 13, 2009
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analysesJackson T Wright, Jeffrey L Probstfield, William C Cushman, et al.
American Journal of Nephrology|April 29, 2011
Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) StudyRaymond R Townsend, Amanda H Anderson, Jing Chen, et al.
Pageof 19

Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Archives of Internal Medicine|April 27, 2005
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Sara Pressel, Barry R Davis, et al.
JAMA Cardiology|March 23, 2017
Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney DiseaseJing Chen, Matthew J Budoff, Muredach P Reilly, et al.
Kidney International|July 17, 2014
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention TrialCarl D Langefeld, Jasmin Divers, Nicholas M Pajewski, et al.
Global Heart|February 19, 2024
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of HypertensionAnthony Rodgers, Abdul Salam, William Cushman, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
The rationale and design of the AASK cohort studyLawrence J Appel, John Middleton, Edgar R Miller, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Genetic African Ancestry and Markers of Mineral Metabolism in CKDOrlando M Gutiérrez, Afshin Parsa, Tamara Isakova, et al.
JAMA|November 21, 2002
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJackson T Wright, George Bakris, Tom Greene, et al.
Hypertension (Dallas, Tex. : 1979)|July 28, 2010
Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary studyRaymond R Townsend, Julio A Chirinos, Afshin Parsa, et al.
Archives of Internal Medicine|May 13, 2009
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analysesJackson T Wright, Jeffrey L Probstfield, William C Cushman, et al.
American Journal of Nephrology|April 29, 2011
Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) StudyRaymond R Townsend, Amanda H Anderson, Jing Chen, et al.
Pageof 19